Trending Topic

3d medical x ray of knee pain with arthritis inflammation and tendon injury, copy space
9 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The use of immune checkpoint inhibitors (ICIs) in treating cancer has greatly improved survival outcomes, particularly in patients with advanced disease for whom successful treatment options have previously been limited. For example, in patients with metastatic melanoma, the median survival time has improved from just 6 months to approximately 6 years with the use of […]

Juvenile Idiopathic Arthritis Awareness Week 2023 – Clare Jacklin, NRAS

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 30th 2023

Juvenile idiopathic arthritis awareness week (JIAAW) is taking place between 3-7 July to raise awareness and dispel misconceptions around JIA, this year’s theme is #BustingJIAMyths, you can take part by entering the ‘JIA Mythbuster’ quiz and joining the conversation on social media using #BustingJIAMyths  and #JIAAW2023. touchIMMUNOLOGY were delighted to talk with CEO Clare Jacklin and support our partner the National Rheumatoid Arthritis Society (NRAS) in improving education around JIA. For more information around JIA, please visit the dedicated NRAS website here: https://jia.org.uk/

Questions

  1. What are the aims of the NRAS campaign JIA Awareness Week (JIAAW)? (0:54)
  2. Could you describe the importance of this year’s theme #BustingJIAMyths? (1:42)
  3. How can the JIA community take part in this year’s awareness week? (3:26)
  4. Please can you outline the importance of JIAAW and how increased physician and patient awareness of JIA might impact disease outcomes? (5:39)

Disclosures: Clare Jacklin discloses serving on advisory boards for the Association of British Pharmaceutical Industry.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

Click here for more information on NRAS.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup